Screener
Proto Labs PRLB Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Proto Labs in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Proto Labs’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 1:58 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001443669-26-000025
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| (Unaudited) | ||
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $123,973 | $110,826 |
| Short-term marketable securities | 12,307 | 17,297 |
| Accounts receivable, net of allowance for credit losses of $2,844 and $2,668 as of March 31, 2026, and December 31, 2025, respectively | 85,553 | 78,962 |
| Inventory | 14,871 | 14,401 |
| Prepaid expenses and other current assets | 10,698 | 9,590 |
Item 1. Financial Statements
FAQ
- What is Proto Labs's cash & equivalents?
- Proto Labs (PRLB) reported cash & equivalents of $123.97M in Q1 2026.
- How has Proto Labs's cash & equivalents changed year-over-year?
- Proto Labs's cash & equivalents increased by 49.9% year-over-year, from $82.69M to $123.97M.
- What is the long-term trend for Proto Labs's cash & equivalents?
- Over 5 years (2020 to 2025), Proto Labs's cash & equivalents has grown at a -2.8% compound annual growth rate (CAGR), from $127.6M to $110.83M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Proto Labs's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude